Role and dynamics of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in burn patients

Stanciu,Adina Elena; Zamfir‑Chiru‑Anton,Adina; Stanciu,Marcel Marian; Gherghe,Mirela; Hainarosie,Razvan; Furtunescu,Florentina Ligia; Gheorghe,Dan Cristian

doi:10.3892/etm.2021.10496

October-2021 Volume 22 Issue 4

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

October-2021 Volume 22 Issue 4

Full Size Image

Article

Role and dynamics of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in burn patients

Authors:
- Adina Elena Stanciu
- Adina Zamfir‑Chiru‑Anton
- Marcel Marian Stanciu
- Mirela Gherghe
- Razvan Hainarosie
- Florentina Ligia Furtunescu
- Dan Cristian Gheorghe
View Affiliations / Copyright

Affiliations: Department of Carcinogenesis and Molecular Biology, ʻProf. Dr. Alexandru Trestioreanu’ Institute of Oncology, 022328 Bucharest, Romania, ENT Department, ʻGrigore Alexandrescu’ Children's Emergency Hospital, 011743 Bucharest, Romania, Electrical Engineering Faculty, ‘Politehnica’ University, 060042 Bucharest, Romania, Department of Nuclear Medicine, ‘Prof. Dr. Alexandru Trestioreanu’ Institute of Oncology, 022328 Bucharest, Romania, ENT Department, ‘Prof. Dr. Dorin Hociota’ Institute of Phonoaudiology and Functional ENT and Cervicofacial Surgery, 050751 Bucharest, Romania, Department of Complementary Sciences, ‘Carol Davila’ University of Medicine and Pharmacy, 050463 Bucharest, Romania, ENT Department, ‘Carol Davila’ University of Medicine and Pharmacy, 050463 Bucharest, Romania
Article Number: 1062
|
Published online on: July 27, 2021

https://doi.org/10.3892/etm.2021.10496
Expand metrics +

Abstract

Burn injuries can trigger tissue changes that can explain the variation in the level of different biochemical markers that can be recorded both locally or systemically. Some events observed in burn wounds such as vascular hyperpermeability have been associated with the release of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) after trauma. Because it is unknown whether the serum levels of MMP‑9 and TIMP‑1 are a consequence of these destructions or a local response to thermal damage, we decided to follow their dynamics. Twenty‑five patients (mean age 49.40±17.55 years) with a total body surface area (TBSA) affected by a thermal burn of <25% and 30 healthy subjects (mean age 49.70±8.04 years) were enrolled in the present study. Enzyme immunoassays were used to measure the serum levels of MMP‑9 and TIMP‑1. Our results showed that MMP‑9 was increased 6.25‑fold immediately after injury compared to the controls and remained on a plateau throughout the 7‑day monitoring period. TIMP‑1 showed an upward trend with an increase of 49.52% on the seventh day after triggering insult. The time‑course of the MMP‑9/TIMP‑1 ratio followed the inverse dynamics of TIMP‑1 starting from a ratio value measured at admission 3.82‑fold higher than the one observed in the healthy volunteers and a highly statistically significant correlation between the values measured at different time‑points during the monitoring period (P<0.001). The results of this retrospective study indicate that the MMP‑9/TIMP‑1 ratio may provide information on local changes over time, starting from the triggering insult, and may be considered as a predictive biomarker of burn evolutivity.

View Figures

View References

1	Wiggins-Dohlvik K, Han MS, Stagg HW, Alluri H, Shaji CA, Oakley RP, Davis ML and Tharakan B: Melatonin inhibits thermal injury-induced hyperpermeability in microvascular endothelial cells. J Trauma Acute Care Surg. 77:899–905. 2014.PubMed/NCBI View Article : Google Scholar
2	Demling RH: The burn edema process: Current concepts. J Burn Care Rehabil. 26:207–227. 2005.PubMed/NCBI
3	Stagg HW, Whaley JG, Tharakan B, Hunter FA, Jupiter D, Little DC, Davis ML, Smythe WR and Childs EW: Doxycycline attenuates burn-induced microvascular hyperpermeability. J Trauma Acute Care Surg. 75:1040–1046. 2013.PubMed/NCBI View Article : Google Scholar
4	Rodriguez D, Morrison CJ and Overall CM: Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim Biophys Acta. 1803:39–54. 2010.PubMed/NCBI View Article : Google Scholar
5	Pantea Stoian A, Mitrofan G, Colceag F, Suceveanu AI, Hainarosie R, Pituru S, Diaconu CC, Timofte D, Nitipir C, Poiana C and Serafinceanu C: Oxidative stress in diabetes. A model of complex thinking applied in medicine. Rev Chim. 69:2515–2519. 2018.
6	Young PK and Grinnell F: Metalloproteinase activation cascade after burn injury: A longitudinal analysis of the human wound environment. J Invest Dermatol. 103:660–664. 1994.PubMed/NCBI View Article : Google Scholar
7	Wysocki AB, Staiano-Coico L and Grinnell F: Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J Invest Dermatol. 101:64–68. 1993.PubMed/NCBI View Article : Google Scholar
8	McCarty SM and Percival SL: Proteases and delayed wound healing. Adv Wound Care (New Rochelle). 2:438–447. 2013.PubMed/NCBI View Article : Google Scholar
9	Dasu MR, Spies M, Barrow RE and Herndon DN: Matrix metalloproteinases and their tissue inhibitors in severely burned children. Wound Repair Regen. 11:177–180. 2003.PubMed/NCBI View Article : Google Scholar
10	Lang TC, Zhao R, Kim A, Wijewardena A, Vandervord J, Xue M and Jackson CJ: A Critical update of the assessment and acute management of patients with severe burns. Adv Wound Care (New Rochelle). 8:607–633. 2019.PubMed/NCBI View Article : Google Scholar
11	Nagy B, Szélig L, Rendeki S, Loibl C, Rézmán B, Lantos J, Bogár L and Csontos C: Dynamic changes of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 after burn injury. J Crit Care. 30:162–166. 2015.PubMed/NCBI View Article : Google Scholar
12	Plichta JK, Holmes CJ, Gamelli RL and Radek KA: Local burn injury promotes defects in the epidermal lipid and antimicrobial peptide barriers in human autograft skin and burn margin: Implications for burn wound healing and graft survival. J Burn Care Res. 38:e212–e226. 2017.PubMed/NCBI View Article : Google Scholar
13	Guo HF, Ali RM, Hamid RA, Chang SK, Rahman MH, Zainal Z and Khaza'ai H: Temporal changes in the cell population and wound healing-related gene expression in deep partial-thickness burn wound model. Biomed Dermatol. 4(5)2020.
14	Suceveanu AI, Mazilu L, Katsiki N, Parepa I, Voinea F, Pantea-Stoian A, Rizzo M, Botea F, Herlea V, Serban D and Suceveanu AP: NLRP3 inflammasome biomarker-could be the new tool for improved cardiometabolic syndrome outcome. Metabolites. 10(448)2020.PubMed/NCBI View Article : Google Scholar
15	Stoian AP, Razvan H, Pietrosanu C, Rusescu A, Andronache LF, Paunica S, Balalau C and Pituru TS: Modern concepts in non-surgical esthetics; a review. J Mind Med Sci. 6:190–195. 2019.
16	Simonetti O, Lucarini G, Cirioni O, Zizzi A, Orlando F, Provinciali M, Di Primio R, Giacometti A and Offidani A: Delayed wound healing in aged skin rat models after thermal injury is associated with an increased MMP-9, K6 and CD44 expression. Burns. 39:776–787. 2013.PubMed/NCBI View Article : Google Scholar
17	Georgescu EF, Mogoantă SŞ, Costache A, Pârvănescu V, Totolici BD, Pătraşcu Ş and Stănescu C: The assessment of matrix metalloproteinase-9 expression and angiogenesis in colorectal cancer. Rom J Morphol Embryol. 56:1137–1144. 2015.PubMed/NCBI
18	Murphy G: Tissue inhibitors of metalloproteinases. Genome Biol. 12(233)2011.PubMed/NCBI View Article : Google Scholar
19	Raeeszadeh-Sarmazdeh M, Do LD and Hritz BG: Metalloproteinases and their inhibitors: Potential for the development of new therapeutics. Cells. 9(1313)2020.PubMed/NCBI View Article : Google Scholar
20	Stanciu AE, Zamfir-Chiru-Anton A, Stanciu MM, Stoian AP, Jinga V, Nitipir C, Bucur A, Pituru TS, Arsene AL, Dragoi CM, et al: Clinical significance of serum melatonin in predicting the severity of oral squamous cell carcinoma. Oncol Lett. 19:1537–1543. 2020.PubMed/NCBI View Article : Google Scholar
21	Stetler-Stevenson WG: Tissue inhibitors of metalloproteinases in cell signaling: Metalloproteinase-independent biological activities. Sci Signal. 1(re6)2008.PubMed/NCBI View Article : Google Scholar
22	Wiggins-Dohlvik K, Oakley RP, Han MS, Stagg HW, Alluri H, Shaji CA, Davis ML and Tharakan B: Tissue inhibitor of metalloproteinase-2 inhibits burn-induced derangements and hyperpermeability in microvascular endothelial cells. Am J Surg. 211:197–205. 2016.PubMed/NCBI View Article : Google Scholar
23	Ulrich D, Noah EM, von Heimburg D and Pallua N: TIMP-1, MMP-2, MMP-9, and PIIINP as serum markers for skin fibrosis in patients following severe burn trauma. Plast Reconstr Surg. 111:1423–1431. 2003.PubMed/NCBI View Article : Google Scholar
24	Stanciu AE: Cytokines in heart failure. Adv Clin Chem. 93:63–113. 2019.PubMed/NCBI View Article : Google Scholar
25	Zurac S, Neagu M, Constantin C, Cioplea M, Nedelcu R, Bastian A, Popp C, Nichita L, Andrei R, Tebeica T, et al: Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors. Oncol Lett. 11:3354–3360. 2016.PubMed/NCBI View Article : Google Scholar
26	Hästbacka J, Fredén F, Hult M, Bergquist M, Wilkman E, Vuola J, Sorsa T, Tervahartiala T and Matrix F: Matrix metalloproteinases-8 and -9 and tissue inhibitor of metalloproteinase-1 in burn patients. A prospective observational study. PLoS One. 10(e0125918)2015.PubMed/NCBI View Article : Google Scholar
27	Lorente L, Martin MM, Labarta L, Diaz C, Solé-Violán J, Blanquer J, Orbe J, Rodriguez JA, Jimenez A, Borreguero-Leon JM, et al: Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. Crit Care. 13(R158)2009.PubMed/NCBI View Article : Google Scholar